Found 0 matching trials
Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases PHASE1 In this phase 1 open label study for patients with type I punctate palmopla...
Show More Location
Soroka Medical Center
Learn More & Join Trial
A Study to Investigate the Safety and Tolerability of MK-0517 in Healthy Subjects (MK-0517-012) PHASE1 This 5-part study will evaluate the safety, tolerability, and pharmacokinet...
Show More Location
Multiple Locations
Learn More & Join Trial
Maternal Vitamin D for Infant Growth (MDIG) Trial PHASE3 The primary aims of this study are: 1) to determine whether maternal prenat...
Show More Location
International Centre for Diarrhoeal Disease Research, Bangladesh
Learn More & Join Trial
Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer PHASE2 This phase II trial studies how well pertuzumab, trastuzumab, and paclitaxe...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
WHO Drug Study for Buruli Ulcer - Comparison of SR8 and CR8 PHASE2 This is a WHO-sponsored trial.
Combination therapy with streptomycin and r...
Show More Location
Pobรจ Treatment Center
Learn More & Join Trial
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers PHASE1 This study is a randomized, open-label, fasted, single dose, crossover stud...
Show More Location
Chonbuk National University Hospital
Learn More & Join Trial
Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer PHASE1 This trial will enroll patients with locally advanced rectal cancer (resect...
Show More Location
Rocky Mountain Cancer Center
Learn More & Join Trial
ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration PHASE1 The purpose of this study is to evaluate the safety and tolerability of int...
Show More Learn More & Join Trial
A Single-Center, Open-Label, Randomized, 3-Treatment Crossover Bioavailability Study of Single Oral Doses of E5501 Old Tablet Formulation Under Fasted Conditions and a New Tablet Formulation Under Fed and Fasted Conditions in Healthy Subjects PHASE1 This study will be a single-center, open-label, randomized, 3-treatment cro...
Show More Learn More & Join Trial
Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting PHASE2 This phase II is studying the side effects and how well carboplatin and pac...
Show More Location
Chao Family Comprehensive Cancer Center
Learn More & Join Trial